Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients

Background: The aim of the study was to assess underlying genetic cause(s), clinical features, and response to therapy in catecholaminergic polymorphic ventricular tachycardia (CPVT) probands. Methods and results: We identified 13 missense mutations in the cardiac ryanodine receptor (RYR2) in 12 pro...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Postma, A, Denjoy, I, Kamblock, J, Alders, M, Lupoglazoff, J, Vaksmann, G, Dubosq-Bidot, L, Sebillon, P, Mannens, M, Guicheney, P, Wilde, A
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Group 2005
Témata:
Letter to JMG
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1735955/
https://ncbi.nlm.nih.gov/pubmed/16272262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jmg.2004.028993
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky